Full Press Release Details
ROCKVILLE, Md., Nov. 06, 2023 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and innovative bioprocessing applications, today announced Company management will participate at two upcoming investor conferences.
Stifel 2023 Healthcare Conference
Fireside Chat on Wednesday, November 15th at 9:10am ET
Stephens Annual Investment Conference
Fireside Chat on Thursday, November 16th at 9:00am CT
A live and archived webcast of the event will be available on the “Events” section of the MaxCyte investor relations website at https://investors.maxcyte.com/.
Spectrum Seismic Collaborative
Nominated Adviser and Joint Corporate Broker
Emma Earl / Freddy Crossley
ICR Consilium Strategic Communications